X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (765) 765
Publication (52) 52
Book Chapter (12) 12
Book Review (11) 11
Magazine Article (3) 3
Conference Proceeding (2) 2
Dissertation (1) 1
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (569) 569
homocysteine (467) 467
male (402) 402
hyperhomocysteinemia (400) 400
homocysteine - blood (364) 364
female (360) 360
index medicus (299) 299
risk factors (296) 296
middle aged (239) 239
hyperhomocysteinemia - complications (202) 202
adult (198) 198
animals (197) 197
nutrition & dietetics (188) 188
plasma homocysteine (179) 179
aged (174) 174
hyperhomocysteinemia - drug therapy (161) 161
hyperhomocysteinemia - blood (151) 151
vascular-disease (142) 142
folic acid (137) 137
folate (128) 128
dietary supplements (127) 127
cardiovascular-disease (118) 118
folic-acid (113) 113
atherosclerosis (112) 112
folic acid - therapeutic use (108) 108
folic acid - blood (103) 103
oxidative stress (101) 101
vitamin b (100) 100
folic acid - administration & dosage (98) 98
rats (96) 96
risk-factor (96) 96
cardiovascular disease (93) 93
metabolism (91) 91
homocysteine - metabolism (87) 87
diet (86) 86
disease (86) 86
mice (85) 85
research (83) 83
health aspects (81) 81
peripheral vascular disease (81) 81
physiological aspects (81) 81
risk (80) 80
vitamin b 12 - blood (80) 80
hyperhomocysteinemia - physiopathology (77) 77
hyperhomocysteinemia - metabolism (75) 75
methylenetetrahydrofolate reductase (74) 74
methionine (70) 70
hyperhomocysteinemia - epidemiology (68) 68
hyperhomocysteinemia - genetics (68) 68
cardiovascular diseases (67) 67
risk factor (66) 66
hyperhomocysteinemia - etiology (65) 65
cardiovascular diseases - etiology (62) 62
prevalence (61) 61
stroke (61) 61
aged, 80 and over (60) 60
nutrition (58) 58
biomarkers - blood (56) 56
methylenetetrahydrofolate reductase - genetics (56) 56
hematology (55) 55
medicine (55) 55
disease models, animal (52) 52
myocardial-infarction (50) 50
biochemistry & molecular biology (49) 49
cardiac & cardiovascular systems (49) 49
vitamin b 12 - therapeutic use (49) 49
coronary-artery-disease (48) 48
case-control studies (47) 47
vitamin b 12 - administration & dosage (47) 47
vitamin b complex - therapeutic use (47) 47
plasma (46) 46
studies (46) 46
treatment outcome (46) 46
prospective studies (45) 45
vitamin b12 (45) 45
adolescent (44) 44
amino acids (43) 43
double-blind method (43) 43
endocrinology & metabolism (42) 42
genotype (42) 42
mortality (42) 42
rats, wistar (42) 42
care and treatment (41) 41
cross-sectional studies (41) 41
endothelial dysfunction (41) 41
hyperhomocysteinemia - diagnosis (41) 41
plasma total homocysteine (41) 41
supplementation (41) 41
analysis (40) 40
endothelium (40) 40
hypertension (40) 40
prevention (40) 40
urology & nephrology (40) 40
endothelium, vascular - physiopathology (39) 39
homocystine (39) 39
rodents (39) 39
folic acid - pharmacology (38) 38
hyperhomocysteinemia - diet therapy (38) 38
medicine, general & internal (38) 38
mutation (38) 38
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (757) 757
Chinese (5) 5
French (5) 5
German (4) 4
Italian (2) 2
Polish (2) 2
Russian (2) 2
Spanish (2) 2
Dutch (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 01/2014, Volume 100, Issue 2, pp. 657 - 666
Journal Article
Nutrients, ISSN 2072-6643, 05/2013, Volume 5, Issue 5, pp. 1531 - 1543
Journal Article
Annual Review of Nutrition, ISSN 0199-9885, 7/2016, Volume 36, Issue 1, pp. 211 - 239
Moderately elevated plasma total homocysteine (tHcy) is a strong modifiable risk factor for vascular dementia and Alzheimer's disease. Prospectively, elevated... 
clinical trial | dementia | folate | cobalamin (vitamin B12) | cognition | Alzheimer's disease | PLASMA TOTAL HOMOCYSTEINE | BRAIN ATROPHY | ALZHEIMERS-DISEASE | FATTY-ACID-METABOLISM | RANDOMIZED CONTROLLED-TRIAL | NUTRITION & DIETETICS | SMALL-VESSEL DISEASE | MEDIAL TEMPORAL-LOBE | WHITE-MATTER HYPERINTENSITIES | PLACEBO-CONTROLLED TRIAL | TRANSIENT CEREBRAL-ISCHEMIA | Hyperhomocysteinemia - epidemiology | Folic Acid - therapeutic use | Folic Acid - adverse effects | Neurodegenerative Diseases - etiology | Nootropic Agents - metabolism | Humans | Neurodegenerative Diseases - prevention & control | Hyperhomocysteinemia - metabolism | Vitamin B 12 - adverse effects | Homocysteine - metabolism | Vitamin B 12 - therapeutic use | Cognitive Dysfunction - prevention & control | Hyperhomocysteinemia - physiopathology | Cognition Disorders - prevention & control | Cognition Disorders - etiology | Cognitive Dysfunction - epidemiology | Aging | Nutritional Status | Dietary Supplements - adverse effects | Vitamin B 6 - metabolism | Risk Factors | Homocysteine - blood | Nootropic Agents - therapeutic use | Cerebrovascular Circulation | Cognitive Dysfunction - etiology | Evidence-Based Medicine | Nootropic Agents - adverse effects | Animals | Neurodegenerative Diseases - physiopathology | Vitamin B 6 - adverse effects | Vitamin B 6 - therapeutic use | Biomarkers | Folic Acid - metabolism | Hyperhomocysteinemia - diet therapy | Cognition Disorders - epidemiology | Neurodegenerative Diseases - epidemiology | Vitamin B 12 - metabolism | Practice Guidelines as Topic | Physiological aspects | Homocysteine | Health aspects | Dementia
Journal Article